Trial Search Results
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
Stanford is currently accepting patients for this trial.
- Clinical diagnosis of RDEB by local dermatologist
- 7 years of age or older
-Medical instability limiting ability to travel to Stanford University Medical Center
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study